VUMERITY 231 mg, gastro-resistant capsule 120 capsules
Active ingredients: FUMARATE DE DIROXIMEL
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule120 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VUMERITY 231 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s)
- Marketing authorisation holder
- BIOGEN NETHERLANDS (PAYS-BAS)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67170230CIP73024168CIP133400930241684Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE DIROXIMELgélule | 231 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.